Cardio-oncology

SEP 7, 2026 · JOURNAL ARTICLE

Cardiovascular disease as a driver of tumor development: epidemiological, mechanistic and bioinformatic insights

Cardio-oncology

A narrative review synthesizing epidemiological observations, animal mechanistic data, and biomarker analysis to propose bidirectional CVD–cancer relationships; lacks prospective clinical evidence or causal proof.

SEP 4, 2026 · JOURNAL ARTICLE

Baseline cardiac biomarkers and inflammatory indices for new-onset ECG abnormalities and survival in patients receiving immune checkpoint inhibitors: a single-center exploratory study

Cardio-oncology

Single-center retrospective cohort with modest discrimination (C-index 0.645), apparent in-sample estimates, and modest effects; exploratory analyses lack prospective validation and cannot yet inform clinical practice.

SEP 2, 2026 · JOURNAL ARTICLE

Safety of immune checkpoint inhibitor rechallenge and mid-term outcomes after suspected cardiovascular immune-related adverse events

Cardio-oncology

A prospective single-centre cohort study with adjudicated endpoints and identified predictors of mid-term CV events, but limited by single-centre design and lack of a comparator arm, providing real results that require confirmation in larger populations.

AUG 18, 2026 · JOURNAL ARTICLE

Cardiovascular effects of chemoradiotherapy in patients with lung cancer: an [18F]FDG PET-CT imaging study

Cardio-oncology

A small single-centre imaging study with surrogate endpoints (calcium score and FDG uptake) showing a signal of chemoradiotherapy-associated aortic atherosclerosis progression, but lacking hard clinical outcomes and requiring confirmation.

AUG 11, 2026 · JOURNAL ARTICLE

EXERT-BCHC: a prospective study of exercise regimens after breast cancer to improve skeletal muscle hypertrophy and conditioning

Cardio-oncology

Small uncontrolled single-arm pilot study with no comparator group and no statistically significant primary outcomes; early-phase feasibility work in a specialized post-cancer population.